Gene · 406949
Papers3,765
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,765
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects of Two Different School-Based Training on Serum miR15b Expression and Lipid Profile of Adolescents with Obesity. | Int J Prev Med | 2022 | 36618534 | PubTator, text mining | PubMed |
| Integrated analysis of necroptosis-related genes for evaluating immune infiltration and colon cancer prognosis. | Front Immunol | 2022 | 36618366 | PubTator, text mining | PubMed |
| Role of miRNA in Melanoma Development and Progression. | Int J Mol Sci | 2022 | 36613640 | PubTator, text mining | PubMed |
MicroRNAs miR-584-5p and miR-425-3p Are Up-Regulated in Plasma of Colorectal Cancer (CRC) Patients: Targeting with Inhibitor Peptide Nucleic Acids Is Associated with Induction of Apoptosis in Colon Cancer Cell Lines. | Cancers (Basel) | 2022 | 36612125 | PubTator, text mining | PubMed |
| Non-Coding RNAs in Airway Diseases: A Brief Overview of Recent Data. | Cancers (Basel) | 2022 | 36612051 | PubTator, text mining | PubMed |
| Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies. | Cancers (Basel) | 2022 | 36612019 | PubTator, text mining | PubMed |
| MicroRNAs (miRNAs): Novel potential therapeutic targets in colorectal cancer. | Front Oncol | 2022 | 36591525 | PubTator, text mining | PubMed |
| Non-additive effect of the DNA methylation inhibitor, 5-Aza-dC, and glass as a culture surface on osteogenic differentiation. | Heliyon | 2022 | 36590514 | PubTator, text mining | PubMed |
| miRNome profiling of lung cancer metastases revealed a key role for miRNA-PD-L1 axis in the modulation of chemotherapy response. | J Hematol Oncol | 2022 | 36587234 | PubTator, text mining | PubMed |
| lncRNA ELFN1-AS1 enhances the progression of colon cancer by targeting miR-4270 to upregulate AURKB. | Open Med (Wars) | 2022 | 36561847 | PubTator, text mining | PubMed |
| The Molecular Mechanisms and Function of miR-15a/16 Dysregulation in Fibrotic Diseases. | Int J Mol Sci | 2022 | 36555676 | PubTator, text mining | PubMed |
| The Mutual Relationship between Glycosylation and Non-Coding RNAs in Cancer and Other Physio-Pathological Conditions. | Int J Mol Sci | 2022 | 36555445 | PubTator, text mining | PubMed |
| Clinical Investigation of Chemotherapeutic Resistance and miRNA Expressions in Head and Neck Cancers: A Thorough PRISMA Compliant Systematic Review and Comprehensive Meta-Analysis. | Genes (Basel) | 2022 | 36553594 | PubTator, text mining | PubMed |
| SGAEMDA: Predicting miRNA-Disease Associations Based on Stacked Graph Autoencoder. | Cells | 2022 | 36552748 | PubTator, text mining | PubMed |
| Recent Advances in the Roles of MicroRNA and MicroRNA-Based Diagnosis in Neurodegenerative Diseases. | Biosensors (Basel) | 2022 | 36551041 | PubTator, text mining | PubMed |
| An update on epigenetic regulation in autoimmune diseases. | J Transl Autoimmun | 2022 | 36544624 | PubTator, text mining | PubMed |
| Tocotrienols: Exciting Biological and Pharmacological Properties of Tocotrienols and Naturally Occurring Compounds, Part II. | Ann Clin Case Rep | 2022 | 36540866 | PubTator, text mining | PubMed |
| miR-20a is upregulated in serum from domestic feline with PKD1 mutation. | PLoS One | 2022 | 36538546 | PubTator, text mining | PubMed |
| Lung cancer patients with chronic obstructive pulmonary disease benefit from anti-PD-1/PD-L1 therapy. | Front Immunol | 2022 | 36532019 | PubTator, text mining | PubMed |
| Prediction of potential small molecule-miRNA associations based on heterogeneous network representation learning. | Front Genet | 2022 | 36531225 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406949/papers?page=25